ALLERFED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Allerfed, and when can generic versions of Allerfed launch?
Allerfed is a drug marketed by Pvt Form and is included in one NDA.
The generic ingredient in ALLERFED is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLERFED?
- What are the global sales for ALLERFED?
- What is Average Wholesale Price for ALLERFED?
Summary for ALLERFED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 5,256 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALLERFED at DailyMed |
![ALLERFED drug patent expirations Drug patent expirations by year for ALLERFED](/p/graph/s/t/ALLERFED-patent-expirations.png)
US Patents and Regulatory Information for ALLERFED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pvt Form | ALLERFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088860-001 | Jan 31, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |